Valuation Rani Therapeutics Holdings, Inc.
Stocks
RANI
US7530181004
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.6153 USD | +0.98% |
|
+1.70% | -54.42% |
Company Valuation: Rani Therapeutics Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 322.3 | 145.8 | 85.92 | 45.64 | 131.7 | 70.33 | - | - |
| Change | - | -54.75% | -41.09% | -46.89% | 188.57% | -46.6% | - | - |
| Enterprise Value (EV) | 322.3 | 77.02 | 37.38 | 45.64 | 131.7 | 70.33 | 70.33 | 70.33 |
| Change | - | -76.1% | -51.46% | 22.08% | 188.57% | -46.6% | 0% | 0% |
| P/E | -38x | -4.61x | -2.5x | -1.3x | -3x | -3.52x | -3.21x | -3.89x |
| PBR | - | 7.91x | - | - | - | - | - | - |
| PEG | - | -0x | -0.64x | 0.1x | 0.1x | 0.1x | -0.33x | 0.2x |
| Capitalization / Revenue | 119x | - | - | 44.4x | 80.6x | 11.2x | 10.6x | 5.06x |
| EV / Revenue | 0x | - | - | 0x | 0x | 11.2x | 10.6x | 5.06x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.9x | -1.65x | -1.65x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.43 | -1.28 | -1.33 | -1.05 | -0.45 | -0.1733 | -0.19 | -0.1567 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.717 | - | - | 1.028 | 1.633 | 6.258 | 6.632 | 13.91 |
| EBITDA | -51.1 | -62.9 | -65.28 | -52.29 | - | - | - | - |
| EBIT 1 | -51.6 | -63.45 | -66.1 | -49.6 | -38.31 | -36.95 | -42.68 | -42.56 |
| Net income 1 | -8.331 | -30.59 | -33.97 | -30.02 | -29.67 | -31.46 | -36.73 | -34.4 |
| Net Debt | - | -68.83 | -48.54 | - | - | - | - | - |
| Reference price 2 | 16.3500 | 5.9000 | 3.3200 | 1.3700 | 1.3500 | 0.6093 | 0.6093 | 0.6093 |
| Nbr of stocks (in thousands) | 19,712 | 24,720 | 25,880 | 33,312 | 97,551 | 115,425 | - | - |
| Announcement Date | 3/31/22 A | 3/22/23 A | 3/20/24 A | 3/31/25 A | 3/26/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.52x | - | - | - | 70.33M | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 23.84x | 26.33x | 15.57x | 0.34% | 38.05B | |
| Weighted average by Cap. | 26.55x | 25.23x | 15.68x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RANI Stock
- Valuation Rani Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
